The t(9;22)(q34;q11), generating the Philadelphia chromosome, is found in more than 90% of patients with chronic myelocytic leukemia (CML). Deletions adjacent to the translocation breakpoint on the derivative chromosome 9 have been described by several groups. These studies revealed two primary points: (1) genomic microdeletions were concomitant with the t(9;22) rearrangement; and (2) the location of the deleted sequence was centromeric to ABL and telomeric to BCR genes. We report on a detailed molecular cytogenetic characterization of chromosomal rearrangements in two CML patients bearing a complex variant t(9;22) and insertions of chromosome 22 sequences in 9q34. Our study shows that the location of the deleted sequences was downstream of...
The breakpoints on chromosome 22 we analyzed by molecular hybridization in 22 cases os chronic myelo...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) ...
The t(9;22)(q34;q11), generating the Philadelphia chromosome, is found in more than 90% of patients ...
The Philadelphia (Ph) chromosome is the cytogenetic hallmark of chronic myeloid leukemia (CML) and i...
Abstract Background The t(9;22)(q34;q11), generating the Philadelphia (Ph) chromosome, is found in m...
The Philadelphia chromosome (Ph), produced by the reciprocal t(9;22)(q34;q11.2), is the cytogenetic ...
A crucial role of segmental duplications (SDs) of the human genome has been shown in chromosomal rea...
Deletions adjacent to the 9/22 translocation breakpoint on the derivative chromosome 9 have recently...
Genomic deletions on the derivative chromosomes bearing the reciprocal fusion gene have recently bee...
Copyright © 2014 F. Malvestiti et al. This is an open access article distributed under the Creative ...
Chronic myeloid leukemia (CML) is a rare myeloproliferative disorder caused by the reciprocal transl...
In 420 Philadelphia positive (Ph+) chronic myeloid leukemia (CML) patients karyotyped at diagnosis i...
BCR/ABL1 gene fusion is the hallmark of chronic myeloid leukemia (CML), and is generated in 5-10% of...
textabstractDuring the last two decades evidence for a close association between the presence of spe...
The breakpoints on chromosome 22 we analyzed by molecular hybridization in 22 cases os chronic myelo...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) ...
The t(9;22)(q34;q11), generating the Philadelphia chromosome, is found in more than 90% of patients ...
The Philadelphia (Ph) chromosome is the cytogenetic hallmark of chronic myeloid leukemia (CML) and i...
Abstract Background The t(9;22)(q34;q11), generating the Philadelphia (Ph) chromosome, is found in m...
The Philadelphia chromosome (Ph), produced by the reciprocal t(9;22)(q34;q11.2), is the cytogenetic ...
A crucial role of segmental duplications (SDs) of the human genome has been shown in chromosomal rea...
Deletions adjacent to the 9/22 translocation breakpoint on the derivative chromosome 9 have recently...
Genomic deletions on the derivative chromosomes bearing the reciprocal fusion gene have recently bee...
Copyright © 2014 F. Malvestiti et al. This is an open access article distributed under the Creative ...
Chronic myeloid leukemia (CML) is a rare myeloproliferative disorder caused by the reciprocal transl...
In 420 Philadelphia positive (Ph+) chronic myeloid leukemia (CML) patients karyotyped at diagnosis i...
BCR/ABL1 gene fusion is the hallmark of chronic myeloid leukemia (CML), and is generated in 5-10% of...
textabstractDuring the last two decades evidence for a close association between the presence of spe...
The breakpoints on chromosome 22 we analyzed by molecular hybridization in 22 cases os chronic myelo...
At diagnosis, about 5% of Chronic Myeloid Leukemia (CML) patients lacks Philadelphia chromosome (Ph)...
The t(9;22)(q34;q11) is evident in more than 90% of patients with chronic myelocytic leukemia (CML) ...